LSGPA Invests an Additional $500,000 in MacuLogix

HARRISBURG, Pa.—The Life Sciences Greenhouse of Central Pennsylvania (LSGPA) has invested an additional $500,000 in MacuLogix, a company that equips eyecare professionals with the instruments, tools and education needed to effectively manage patients with Age-related Macular Degeneration (AMD). The investment was part of a syndicate with other, unnamed investors and brings LSGPA’s total investment in the Middletown, Pa.-based firm to over $2 million.

LSGPA invests in technology that helps to diagnose, monitor and treat AMD well before vision loss occurs. MacuLogix’s AdaptDx technology is designed to make early detection of AMD easier, faster and more reliable.

Be the first to comment on "LSGPA Invests an Additional $500,000 in MacuLogix"

Leave a comment

Your email address will not be published.